Skip to main content

Perspective Therapeutics, Inc.

CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000728387

In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Perspective Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
45
+4 vs. Q3 2021
Shares held
17.5M
+1.66M (+10.5%) vs. Q3 2021
Total value
$6.78M
−$3.20M (−32.1%) vs. Q3 2021
New holders
10
7 more added
Sold out
6
9 more reduced

2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CATX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 45 institutions
Q1 2021: 57 institutionsQ2 2021: 48 institutionsQ3 2021: 43 institutionsQ4 2021: 45 institutionsQ1 2022: 39 institutionsQ2 2022: 43 institutionsQ3 2022: 35 institutionsQ4 2022: 48 institutionsQ1 2023: 42 institutionsQ2 2023: 50 institutionsQ3 2023: 49 institutionsQ4 2023: 52 institutionsQ1 2024: 104 institutionsQ2 2024: 105 institutionsQ3 2024: 127 institutionsQ4 2024: 135 institutionsQ1 2025: 112 institutionsQ2 2025: 98 institutionsQ3 2025: 105 institutionsQ4 2025: 117 institutionsQ1 2026: 138 institutionsQ2 2026: 131 institutions
Value heldQ4 2021: $6.78M
Q1 2021: $20.2MQ2 2021: $13.9MQ3 2021: $9.99MQ4 2021: $6.78MQ1 2022: $5.79MQ2 2022: $5.19MQ3 2022: $3.70MQ4 2022: $4.26MQ1 2023: $17.8MQ2 2023: $22.0MQ3 2023: $9.99MQ4 2023: $14.7MQ1 2024: $294.6MQ2 2024: $384.9MQ3 2024: $654.9MQ4 2024: $150.7MQ1 2025: $96.4MQ2 2025: $146.3MQ3 2025: $150.1MQ4 2025: $105.0MQ1 2026: $333.1MQ2 2026: $297.6M
Institutions holding CATX and their total value by quarter
QuarterHoldersValue
Q2 2026131$297.6M
Q1 2026138$333.1M
Q4 2025117$105.0M
Q3 2025105$150.1M
Q2 202598$146.3M
Q1 2025112$96.4M
Q4 2024135$150.7M
Q3 2024127$654.9M
Q2 2024105$384.9M
Q1 2024104$294.6M
Q4 202352$14.7M
Q3 202349$9.99M
Q2 202350$22.0M
Q1 202342$17.8M
Q4 202248$4.26M
Q3 202235$3.70M
Q2 202243$5.19M
Q1 202239$5.79M
Q4 202145$6.78M
Q3 202143$9.99M
Q2 202148$13.9M
Q1 202157$20.2M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Perspective Therapeutics, Inc.; share changes are against Q3 2021.

Institutions holding CATX in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc6,066,192$2.35M0.00%−54,317−0.9%Reduced
Perkins Capital Management Inc2,801,000$1.09M0.73%+1,248,000+80.4%Added
BlackRock Inc.2,438,273$945.0K0.00%−24,522−1.0%Reduced
Geode Capital Management, LLC1,119,070$433.0K0.00%00.0%Unchanged
Renaissance Technologies LLC980,906$380.0K0.00%−212,727−17.8%Reduced
Highland Private Wealth Management972,038$377.0K0.05%+125,000+14.8%Added
Bard Associates Inc619,200$240.0K0.08%+71,000+13.0%Added
State Street Corp519,042$201.0K0.00%00.0%Unchanged
Taylor & Morgan Wealth Management, LLC340,000$132.0K0.11%+340,000New
Northern Trust Corp261,549$101.0K0.00%00.0%Unchanged
Bridgeway Capital Management, LLC184,000$71.0K0.00%−90,000−32.8%Reduced
Susquehanna International Group, LLP165,081$64.0K0.00%+165,081New
UBS Group AG121,943$47.0K0.00%+79,467+187.1%Added
Creative Planning114,500$44.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp99,229$39.0K0.00%00.0%Unchanged
Morgan Stanley76,233$30.0K0.00%+90.0%Added
Price T Rowe Associates Inc61,500$24.0K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc55,471$22.0K0.00%00.0%Unchanged
Crestwood Advisors Group LLC54,824$21.0K0.00%00.0%Unchanged
AdvisorNet Financial, Inc44,560$17.0K0.00%+2,012+4.7%Added
Virtu Financial LLC40,836$16.0K0.00%−5,821−12.5%Reduced
Cerity Partners LLC40,000$16.0K0.00%00.0%Unchanged
Jane Street Group, LLC42,347$16.0K0.00%+42,347New
Two Sigma Advisers, LP39,600$15.0K0.00%+39,600New
Bremer Bank National Association29,411$11.0K0.00%00.0%Unchanged
Commonwealth Equity Services, LLC26,284$10.0K0.00%−13,500−33.9%Reduced
Royal Bank of Canada25,692$10.0K0.00%−1,009−3.8%Reduced
Victory Capital Management Inc20,644$8.00K0.00%−575−2.7%Reduced
TMD Wealth Management, LLC20,000$8.00K0.00%00.0%Unchanged
Millennium Management LLC21,439$8.00K0.00%+21,439New
Raymond James Financial Services Advisors, Inc.17,500$7.00K0.00%00.0%Unchanged
Ameriprise Financial Inc18,000$7.00K0.00%+18,000New
Auxier Asset Management14,218$6.00K0.00%00.0%Unchanged
Capital Advisors Inc10,000$4.00K0.00%00.0%Unchanged
Wealth Effects LLC10,000$4.00K0.00%+10,000New
Tower Research Capital LLC (TRC)8,077$3.00K0.00%+8,077New
Wells Fargo & Company6,151$2.00K0.00%+4+0.1%Added
JNBA Financial Advisors5,000$2.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.1,500$1.00K0.00%00.0%Unchanged
TD Waterhouse Canada Inc.2,000$8020.00%+2,000New
Horizon Financial Services, LLC350$1360.00%00.0%Unchanged
Arcadia Investment Advisors LLC222$860.00%00.0%Unchanged
Bank of America Corp206$00.00%−517−71.5%Reduced
FNY Investment Advisers, LLC810$00.00%00.0%Unchanged
Chilton Capital Management LLC500$00.00%+500New
Marshall Wace, LLP0$00.00%−48,421−100.0%Sold out
Chicago Partners Investment Group LLC0$00.00%−34,500−100.0%Sold out
Citadel Advisors LLC0$00.00%−10,798−100.0%Sold out
Stratos Wealth Partners, LTD.0$00.00%−10,000−100.0%Sold out
Total Clarity Wealth Management, Inc.0$00.00%−4,143−100.0%Sold out
Arkadios Wealth Advisors0$00.00%−500−100.0%Sold out
Sonora Investment Management, LLC––––Not filed
Wealth Quarterback LLC––––Not filed